The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from CNW Group

/R E P E A T -- TSO3: conference call and webcast for the 2012 annual financial results/

Wednesday, March 20, 2013

/R E P E A T -- TSO3: conference call and webcast for the 2012 annual financial results/07:00 EDT Wednesday, March 20, 2013Ticker Symbol: TOS/TSXShares Outstanding: 72,888,182QUEBEC CITY, March 7, 2013 /CNW Telbec/ - TSO3 Inc. ("TSO3") (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, today announced that it will report the Company's annual financial results ending December 31, 2012, on Wednesday, March 20, 2013. TSO3 will host a conference call at 10:30 A.M. (EDT) the same day.Analysts and institutional investors are invited to participate. The numbers to dial for access are 514-807-9895 (Montréal area), 647-427-7450 (Toronto area) or the toll-free number 1-888-231-8191. Other interested parties may listen to the live Webcast of the Conference Call accessible via TSO3's Website at: The Webcast will be archived for 90 days.About TSO3TSO3, founded in Québec City in 1998, specializes in the research and development of innovative, high-performance medical instrument sterilization technology with high commercial potential. TSO3 designs products for sterile processing areas in the hospital environment and offers an advantageous replacement solutions to other low temperature sterilization processes currently used in hospitals. For more information about TSO3, visit the Company's Web site at www.tso3.comThe statements in this release and oral statements made by representatives of TSO3 relating to matters that are not historical facts (including, without limitation, those regarding the timing or outcome of any financing undertaken by TSO3) are forward-looking statements that involve certain risks, uncertainties and hypotheses, including, but not limited to, general business and economic conditions, the condition of the financial markets, the ability of TSO3 to obtain financing on favourable terms and other risks and uncertainties.SOURCE: TSO3 Inc.For further information: Caroline Côté Director - Investor and Business Relations (418) 651-0003, Ext. 237 Email: